🔗 Share this article

Treasury head Reeves has stated she is preparing "specific steps to tackle household expense pressures" in next month's Budget.

Speaking to media outlets, she emphasized that curbing inflation is a shared responsibility of both the government and the Bank of England.

The United Kingdom's price growth is expected to be the most elevated among the G7 advanced economies this year and next.

Potential Utility Bill Interventions

Sources suggest the administration could intervene to bring down energy bills, such as by reducing the current 5% rate of VAT charged on energy.

A further possibility is to lower some of the government charges currently added to bills.

Fiscal Limitations and Analyst Predictions

The government will receive the next assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much room there is for such actions.

The expectation from the majority of economists is that the Chancellor will have to announce tax rises or expenditure reductions in order to fulfill her voluntary borrowing rules.

Previously on the same day, estimates suggested there was a twenty-two billion pound gap for the Treasury chief to resolve, which is at the more modest range of projections.

"It is a joint job between the Bank of England and the administration to further reduce some of the causes of inflation," Reeves told reporters in Washington, at the annual meetings of the IMF and global financial institution.

Revenue Commitments and Global Issues

While much of the focus has been on likely tax increases, the Treasury chief said the latest information from the OBR had not altered her vow to campaign commitments not to increase tax levels on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable global environment" with rising international and trade tensions for the fiscal revenue measures, probably to be directed on those "most able to pay."

International Trade Tensions

Addressing apprehensions about the United Kingdom's economic relations with the Asian nation she said: "The UK's national security always take priority."

Last week's statement by China to strengthen export controls on rare earths and other materials that are crucial for high-technology manufacturing led American leader Donald Trump to propose an additional 100% import tax on goods from China, increasing the possibility of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary called China's move "commercial pressure" and "a international production control attempt."

Asked about considering the US offer to participate in its conflict with China, Reeves said she was "deeply worried" by China's actions and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "damaging for the global economy and causes further headwinds."

"In my view there are sectors where we need to confront China, but there are also important opportunities to trade with Chinese markets, including financial services and other sectors of the economic system. We've got to get that equilibrium right."

The Treasury chief also stated she was cooperating with other major economies "regarding our own critical minerals approach, so that we are less reliant."

Health Service Medicine Costs and Investment

The Chancellor also acknowledged that the cost the NHS spends on pharmaceuticals could rise as a result of current discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and capital.

Some of the world's largest drug companies have said lately that they are either pausing or scrapping projects in the United Kingdom, with some blaming the modest returns they are obtaining.

Last month, the government science advisor said the price the health service pays for drugs would need to rise to halt firms and pharmaceutical investment departing from the United Kingdom.

Reeves told the BBC: "It has been observed due to the cost structure, that medical research, new drugs have not been provided in the UK in the extent that they are in other EU nations."

"The objective is to make sure that individuals receiving care from the National Health Service are able to access the finest critical treatments in the world. And so we are examining this situation, and... looking to attract additional funding into Britain."